Sargent Bickham Lagudis’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $9.44K | Hold |
204
| – | – | ﹤0.01% | 736 |
|
|
2022
Q3 | $8K | Sell |
204
-79
| -28% | -$3.1K | ﹤0.01% | 717 |
|
|
2022
Q2 | $11K | Buy |
283
+79
| +39% | +$3.07K | ﹤0.01% | 677 |
|
|
2022
Q1 | $9K | Hold |
204
| – | – | ﹤0.01% | 722 |
|
|
2021
Q4 | $9K | Hold |
204
| – | – | ﹤0.01% | 720 |
|
|
2021
Q3 | $9K | Hold |
204
| – | – | ﹤0.01% | 730 |
|
|
2021
Q2 | $9K | Hold |
204
| – | – | ﹤0.01% | 722 |
|
|
2021
Q1 | $8K | Hold |
204
| – | – | ﹤0.01% | 731 |
|
|
2020
Q4 | $7K | Sell |
204
-144
| -41% | -$4.94K | ﹤0.01% | 694 |
|
|
2020
Q3 | $13K | Hold |
348
| – | – | ﹤0.01% | 556 |
|
|
2020
Q2 | $12K | Sell |
348
-871
| -71% | -$30K | ﹤0.01% | 548 |
|
|
2020
Q1 | $40K | Buy |
1,219
+144
| +13% | +$4.73K | 0.01% | 371 |
|
|
2019
Q4 | $49K | Buy |
+1,075
| New | +$49K | 0.01% | 387 |
|
|
2019
Q2 | – | Sell |
-700
| Closed | -$27K | – | 757 |
|
|
2019
Q1 | $27K | Hold |
700
| – | – | ﹤0.01% | 469 |
|
|
2018
Q4 | $25K | Sell |
700
-321
| -31% | -$11.5K | ﹤0.01% | 457 |
|
|
2018
Q3 | $39K | Buy |
+1,021
| New | +$39K | ﹤0.01% | 404 |
|
|
2018
Q1 | – | Sell |
-398
| Closed | -$10K | – | 761 |
|
|
2017
Q4 | $10K | Buy |
398
+255
| +178% | +$6.41K | ﹤0.01% | 602 |
|
|
2017
Q3 | $4K | Hold |
143
| – | – | ﹤0.01% | 705 |
|
|
2017
Q2 | $4K | Buy |
+143
| New | +$4K | ﹤0.01% | 663 |
|